TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Modalis Therapeutics Corporation ( (JP:4883) ) has provided an update.
Modalis Therapeutics Corporation has completed the pay-in procedures for issuing new shares as part of a restricted-stock-based remuneration plan for its subsidiary employees. This issuance involves 2,300 common shares at a price of 75 yen per share, reflecting the company’s commitment to incentivizing its workforce and potentially enhancing its operational efficiency.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a biotechnology company listed on the Tokyo Stock Exchange, focused on developing innovative therapeutic solutions. The company specializes in gene therapy technologies and aims to address unmet medical needs in the healthcare industry.
Average Trading Volume: 1,710,715
Technical Sentiment Signal: Sell
Current Market Cap: Yen5.69B
For detailed information about 4883 stock, go to TipRanks’ Stock Analysis page.